about
Neuropathy target esterase gene mutations cause motor neuron diseaseThe effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort studyChlorpyrifos exposure and biological monitoring among manufacturing workersIdentification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers.Modeling the tertiary structure of the patatin domain of neuropathy target esterase.Mechanism of aging of mipafox-inhibited butyrylcholinesterase.Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injuryMotor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis.Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.Biomarkers of drug-induced vascular injury.The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing.Neuropathy target esterase (NTE): overview and future.Common mechanism of toxicity: a case study of organophosphorus pesticides.Biosensor analysis of blood esterases for organophosphorus compounds exposure assessment: approaches to simultaneous determination of several esterases.Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics.Probing the active sites of butyrylcholinesterase and cholesterol esterase with isomalathion: conserved stereoselective inactivation of serine hydrolases structurally related to acetylcholinesterase.Evidence for the nitric oxide pathway as a potential mode of action in fenoldopam-induced vascular injury.Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates.Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.The effects of occupational exposure to chlorpyrifos on the neurologic examination of central nervous system function: a prospective cohort study.Absence of sensory neuropathy among workers with occupational exposure to chlorpyrifos.Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model.Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.Fluorinated alpha-aminophosphonates--a new type of irreversible inhibitors of serine hydrolases.Improved electrochemical analysis of neuropathy target esterase activity by a tyrosinase carbon paste electrode modified by 1-methoxyphenazine methosulfate.Aging of mipafox-inhibited human acetylcholinesterase proceeds by displacement of both isopropylamine groups to yield a phosphate adduct.Kinetics and mechanism of inhibition of serine esterases by fluorinated carbethoxy 1-aminophosphonates.Dose-effect analyses of occupational chlorpyrifos exposure and peripheral nerve electrophysiology.Chlorpyrifos: assessment of potential for delayed neurotoxicity by repeated dosing in adult hens with monitoring of brain acetylcholinesterase, brain and lymphocyte neurotoxic esterase, and plasma butyrylcholinesterase activities.Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease.Inhibition of neurotoxic esterase in vitro by novel carbamates.Relative potencies of the four stereoisomers of isomalathion for inhibition of hen brain acetylcholinesterase and neurotoxic esterase in vitro.Effects of occupational exposure to chlorpyrifos on neuropsychological function: a prospective longitudinal study.Tethered lipid bilayers on electrolessly deposited gold for bioelectronic applications.Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseasesEsterase profile of O-phosphorylated ethyltrifluorolactates in prediction of their therapeutic and toxic effects
P50
Q24655586-84C5651E-9A4B-45D2-B7AC-10C31BC577A7Q28393832-E8399CC5-F374-481A-823A-A935E48E1953Q28397419-F6A1169B-D9E9-46D6-9FAD-AE28DDA8FE95Q31016660-02315F99-41BA-4CCB-841C-DED34318ECB3Q31091335-FA07C825-9DFE-4754-86DF-903A1611F982Q33275552-9B1A5AC5-A953-4043-801D-DECB3DE620B9Q33857017-4CB12BE6-018E-47EF-BAD9-B74E89520FFBQ34466077-207DE578-8599-4D4A-A911-57F604BA0830Q35026581-D0BFFFC0-F6F4-48E9-8B5F-830364654FC3Q35026594-5B71E736-D7DF-4349-8EBE-CCE56CC24DB6Q36176683-2D06264C-4405-4508-86F0-6E3B70074327Q37216287-9D722463-6A0E-4541-A222-DD91552EE3CEQ38065626-3FA5BB8B-4EFF-4F6F-8DE0-3DFC226B61B9Q41728715-C05052C5-7888-46BB-BB3C-AF8A432B65CEQ43185437-7320D299-E65A-4EEB-B122-459E04FE1ED2Q43283622-89101E03-DADA-4517-9CF8-4640F79D6FABQ43674177-683AE92C-1AD7-45A9-9332-9C84D673E48AQ44152031-605EB2A7-A488-4A4C-95D3-B4B51F198EC4Q44440385-B8F583C5-427C-4C60-A3B5-0197F90C72DFQ44468803-7E9239A8-A2C4-4C5E-B02F-3E285175DF70Q44838981-D23D4ACD-5AB6-4FCD-8FF5-F34F412A9B94Q44873412-2D551AF7-1B13-4D0F-A4C2-72AC454A8D31Q45201848-DB8E87F3-619C-4D64-9F62-E394E42601C7Q46118905-84E18543-DD24-4607-BD29-78FD28E9168EQ46451061-85DDA203-E561-42E5-B6F3-8E65D65A2DC7Q46699682-31244135-4D9D-406A-8CE8-FB8238E0EC50Q46950767-0A8D93D6-610B-4000-A12B-1D8041DC0F0BQ47704916-8E5C2B49-4394-4C1D-9CCC-A29B988E4DCBQ47806920-9D9F0227-0C42-4F3F-9FA2-C87A54F2774EQ48263887-30052FD7-36F3-452B-88E9-CEE87A01A687Q48436572-0E23BCA2-5E30-415E-9C4C-ED6BDA1C5942Q48787976-A3172836-BB09-40B0-8AF7-766B814FB5C4Q48955201-54992840-12CE-4AC1-B7A4-1EABCF24D95FQ50694614-29EADB69-319D-4849-9D78-BAA846E11BD3Q51096027-81DA4EE4-D1F8-4E60-A438-851337772145Q64077918-CBDA1F5C-D9AD-4C83-A287-232256E89175Q84075395-0ACB4394-AAB9-483E-B908-3F94C8EDC8AB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rudy J Richardson
@nl
Rudy J Richardson
@sl
Rudy J. Richardson
@en
Rudy J. Richardson
@es
type
label
Rudy J Richardson
@nl
Rudy J Richardson
@sl
Rudy J. Richardson
@en
Rudy J. Richardson
@es
prefLabel
Rudy J Richardson
@nl
Rudy J Richardson
@sl
Rudy J. Richardson
@en
Rudy J. Richardson
@es
P214
P227
P244
P106
P1153
35519059400
P21
P214
P227
1129184250
P244
P31
P496
0000-0002-2028-5723
P569
1945-01-01T00:00:00Z
P734
P7859
lccn-n82208509